Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artemisia eriantha extract is a botanical extract derived from the *Artemisia eriantha* plant, a subendemic species native to the Central Apennines of Italy. Traditionally used in folk medicine for its antibacterial, antifungal, anthelmintic, and antispasmodic properties, the extract is currently under investigation in preclinical in vitro studies for the treatment of hepatocellular carcinoma (HCC). The extract contains a complex mixture of monoterpenes (e.g., sabinene, thujones) and sesquiterpenes (e.g., β-caryophyllene). Its mechanism of action involves the dysregulation of cell cycle regulatory proteins, including cyclin D1, cyclin E, and p27, and the activation of the p53-p21 apoptotic pathway, which collectively inhibit cancer cell proliferation and migration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on artemisia eriantha extract.